Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. [electronic resource]
Producer: 20030912Description: 756-62 p. digitalISSN:- 0006-4971
- Aged
- Bone Marrow Transplantation -- adverse effects
- Busulfan
- Cause of Death
- Cyclosporine -- therapeutic use
- Female
- Graft vs Host Disease -- epidemiology
- Hematologic Neoplasms -- therapy
- Humans
- Immunosuppressive Agents -- therapeutic use
- Incidence
- Intestines -- pathology
- Life Tables
- Liver -- pathology
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Mycophenolic Acid -- analogs & derivatives
- Organ Specificity
- Peripheral Blood Stem Cell Transplantation -- adverse effects
- Retrospective Studies
- Severity of Illness Index
- Skin -- pathology
- Survival Analysis
- Time Factors
- Tissue Donors
- Transplantation Conditioning
- Vidarabine -- analogs & derivatives
- Washington -- epidemiology
- Whole-Body Irradiation
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.